Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2020 December;61(6) > The Journal of Cardiovascular Surgery 2020 December;61(6):675-80

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW  EMERGENT TEVAR 

The Journal of Cardiovascular Surgery 2020 December;61(6):675-80

DOI: 10.23736/S0021-9509.20.11595-7

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Emergent thoracic endovascular aortic aneurysm repair for ruptured aneurysm: in-hospital and long-term results

Priya B. PATEL, Marc L. SCHERMERHORN

Division of Vascular and Endovascular Surgery, Department of Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA



The use of thoracic endovascular aortic repair (TEVAR) has rapidly increased following Food and Drug Administration (FDA) approval in 2005. Initially used for the repair of intact thoracic aneurysms and aortic dissections, TEVAR is now routinely used for the treatment of ruptured thoracic aortic aneurysm as well. Emergent TEVAR for the repair of ruptured aneurysm has demonstrated improved perioperative mortality and morbidity compared to traditional open repair. Spinal cord ischemia and permanent paraplegia rates are also lower following TEVAR compared to open repair. However, TEVAR requires routine surveillance and has demonstrated the need for reintervention compared to open repair. Furthermore, the perioperative survival benefits of TEVAR were attenuated on mid-term and long-term survival analysis.


KEY WORDS: Emergencies; Rupture; Aortic aneurysm, thoracic

top of page